Senechal, Isabelle
Vogiatzakis, Nikolaos
Andres, Maria Sol
Tong, Jieli
Ramalingam, Sivatharshini
Rosen, Stuart D
Lyon, Alexander R
Nazir, Muhummad Sohaib
Article History
Received: 11 January 2024
Accepted: 18 March 2024
First Online: 11 April 2024
Declarations
:
: The authors declare no competing interests.
: ARL has received speaker, advisory board or consultancy fees and/or research grants from Myocardial Solutions, Pfizer, Novartis, Servier, Astra Zeneca, Amgen, Takeda, Roche, Janssens-Cilag Ltd, Clinigen, Eli Lily, Eisai Ltd, Bristol Myers Squibb, Ferring Pharmaceuticals, Boehringer Ingelheim, iOWNA Health Ltd and Heartfelt Technologies Ltd. The remaining authors have nothing to disclose.